Table 2. FEV1and VC on Each Study Day and Posttreatment with Lidocaine, Salbutamol, Combined Lidocaine and Salbutamol, or Placebo (n = 15)

Table 2. FEV1and VC on Each Study Day and Posttreatment with Lidocaine, Salbutamol, Combined Lidocaine and Salbutamol, or Placebo (n = 15)
Table 2. FEV1and VC on Each Study Day and Posttreatment with Lidocaine, Salbutamol, Combined Lidocaine and Salbutamol, or Placebo (n = 15)
Close Modal

or Create an Account

Close Modal
Close Modal